Caris Life Sciences, Inc.
CAI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 6/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $753 | $719 | $31 | – |
| Short-Term Investments | $2 | $2 | $2 | – |
| Receivables | $27 | $51 | $80 | – |
| Inventory | $49 | $41 | $37 | – |
| Other Curr. Assets | $4 | $4 | $9 | – |
| Total Curr. Assets | $854 | $833 | $171 | – |
| Property Plant & Equip (Net) | $64 | $61 | $62 | – |
| Goodwill | $19 | $19 | $19 | – |
| Intangibles | $0 | $0 | $0 | – |
| Long-Term Investments | $0 | $0 | $0 | – |
| Tax Assets | $0 | $0 | $0 | – |
| Other NC Assets | $47 | $41 | $39 | – |
| Total NC Assets | $130 | $122 | $120 | – |
| Other Assets | $0 | $0 | $0 | – |
| Total Assets | $985 | $955 | $292 | – |
| Liabilities | – | – | – | – |
| Payables | $29 | $29 | $24 | – |
| Short-Term Debt | $0 | $0 | $60 | – |
| Tax Payable | $0 | $0 | $0 | – |
| Deferred Revenue | $0 | $5 | $8 | – |
| Other Curr. Liab. | $3 | $14 | $33 | – |
| Total Curr. Liab. | $86 | $90 | $163 | – |
| LT Debt | $376 | $374 | $317 | – |
| Deferred Rev, NC | $0 | $0 | $0 | – |
| Deferred Tax Liab, NC | $0 | $0 | $0 | – |
| Other NC Liab. | $0 | $0 | $2,375 | – |
| Total NC Liab. | $420 | $412 | $2,729 | – |
| Other Liabilities | $0 | $0 | $0 | – |
| Cap. Leases | $50 | $45 | $43 | – |
| Total Liabilities | $506 | $502 | $2,891 | – |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | – |
| Common Stock | $0 | $0 | $0 | – |
| Retained Earnings | -$2,631 | -$2,655 | -$2,583 | – |
| AOCI | $1 | $1 | $0 | – |
| Other Equity | $0 | $0 | $0 | – |
| Total Equity | $478 | $453 | -$2,600 | – |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | – |
| Total Liab. & Tot. Equity | $985 | $955 | $292 | – |
| Net Debt | -$377 | -$345 | $346 | $0 |